Single High-Sensitivity Point-of-Care Whole-Blood Cardiac Troponin i Measurement to Rule Out Acute Myocardial Infarction at Low Risk

SAMIE Investigators, Fred S. Apple*, Stephen W. Smith*, Jaimi H. Greenslade*, Yader Sandoval*, William Parsonage*, Isuru Ranasinghe*, Niranjan Gaikwad*, Karen Schulz*, Laura Stephensen*, Christian W. Schmidt*, Brynn Okeson*, Louise Cullen*, Rebecca Hancock, Gerben Keijzers

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

22 Citations (Scopus)

Abstract

Background: 

High-sensitivity cardiac troponin (hs-cTn) laboratory assays are used to rule out myocardial infarction (MI) on presentation, but prolonged result turnaround times can delay patient management. Our primary aim was to identify patients at low risk of index MI using a rapid point-of-care (POC) whole-blood hs-cTnI assay at presentation with potential early patient discharge. 

Methods:

Consecutive patients presenting to the emergency department from 2 prospective observational studies with suspected acute coronary syndrome were enrolled. A POC hs-cTnI assay (Atellica VTLi) threshold using whole blood at presentation, which resulted in a negative predictive value of ≥99.5% and sensitivity of >99% for index MI, was derived (SEIGE [Safe Emergency Department Discharge Rate]) and validated with plasma (SAMIE [Suspected Acute Myocardial Infarction in Emergency]). Event adjudications were established with hs-cTnI assay results from routine clinical care. The primary outcome was MI at 30 days. 

Results:

A total of 1086 patients (8.1% with MI) were enrolled in a US derivation cohort (SEIGE) and 1486 (5.5% MI) in an Australian validation cohort (SAMIE). A derivation whole-blood POC hs-cTnI concentration of <4 ng/L provided a sensitivity of 98.9% (95% CI, 93.8%-100%) and negative predictive value of 99.5% (95% CI, 97.2%-100%) for ruling out MI. In the validation cohort, the sensitivity was 98.8% (95% CI, 93.3%-100%), and negative predictive value was 99.8% (95% CI, 99.1%-100%); 17.8% and 41.8%, respectively, were defined as low risk for discharge. The 30-day adverse cardiac events were 0.1% (n=1) for SEIGE and 0.8% (n=5) for SAMIE. 

Conclusions: 

A POC whole-blood hs-cTnI assay permits accessible, rapid, and safe exclusion of MI and may expedite discharge from the emergency department. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT04772157. URL: https://www.australianclinicaltrials.gov.au/anzctr_feed/form; Unique identifier: 12621000053820.

Original languageEnglish
Pages (from-to)1918-1929
Number of pages12
JournalCirculation
Volume146
Issue number25
DOIs
Publication statusPublished - 31 Oct 2022

Fingerprint

Dive into the research topics of 'Single High-Sensitivity Point-of-Care Whole-Blood Cardiac Troponin i Measurement to Rule Out Acute Myocardial Infarction at Low Risk'. Together they form a unique fingerprint.

Cite this